Huang, Weiting
Koh, Tracy
Tromp, Jasper
Chandramouli, Chanchal
Ewe, See Hooi
Ng, Choon Ta
Lee, Audry Shan Yin
Teo, Louis Loon Yee
Hummel, Yoran
Huang, Feiqiong
Lam, Carolyn Su Ping
Article History
Received: 16 November 2023
Accepted: 17 May 2024
First Online: 12 June 2024
Competing interests
: JT is supported by the National University of Singapore Start-up grant, the tier 1 grant from the ministry of education and the CS-IRG New Investigator Grant from the National Medical Research Council; has received consulting or speaker fees from Daiichi-Sankyo, Boehringer Ingelheim, Roche diagnostics and Us2.ai, co-owns patent US-10702247-B2. CC reports philanthropic research grants from Lee Foundation Singapore and consulting/speaker fees from Boehringer Ingelheim, Sanofi Aventis and Us2.ai. YMH and FH are employees of Us2.ai. CSPL is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from NovoNordisk and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Alleviant Medical, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., Recardio Inc, ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai. All other authors declare no competing interests.